Patients with refractory and difficult-to-treat Inflammatory Bowel Disease are underrepresented in randomized clinical trials

被引：0
|
作者：
Parigi, T. L. [1 ,2 ,3 ]
Solitano, V [4 ,5 ]
Mekonnen, H. [5 ]
Yuan, Y. [5 ]
Jairath, V [5 ]
Danese, S. [3 ]
机构：
[1] IRCCS San Raffaele Hosp, Dept Gastroenterol & Endoscopy, Milan, Italy
[2] Case Western Reserve Univ, Dept Pathol, Cleveland, OH USA
[3] Univ Vita Salute San Raffaele, Div Immunol Transplantat & Infect Dis, Milan, Italy
[4] Univ Vita Salute San Raffaele, Div Immunol Transplantat & Infect Dis, Milan, Italy
[5] Western Univ, Dept Med, Div Gastroenterol, London, ON, Canada
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1332
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1158
引用
收藏
页码：I2114 / I2115
页数：2
相关论文
共 50 条
  • [1] MEDICAL-MANAGEMENT OF PATIENTS WITH DIFFICULT-TO-TREAT INFLAMMATORY BOWEL-DISEASE
    VANHOGEZAND, RA
    NETHERLANDS JOURNAL OF MEDICINE, 1994, 45 (02): : 55 - 59
  • [2] Defining difficult-to-treat inflammatory bowel disease: why and how
    Danese, Silvio
    Parigi, Tommaso Lorenzo
    Peyrin-Biroulet, Laurent
    Ghosh, Subrata
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (07): : S20 - S22
  • [3] Difficult-to-treat Inflammatory Bowel Disease in Latin American countries: prevalence and clinical characteristics
    Flores, C.
    Yamamoto, J.
    Froes, R.
    Lasa, J. S.
    Balderramo, D.
    Martinez, S. B.
    Banos, F. J.
    Iade, B.
    Gomes, T.
    Holguin, N. N. Parra
    Zamora, D. A. Andrade
    Azevedo, F.
    Saes, J.
    Ferreira, A. Yaeza
    Veitia, G.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2275 - i2277
  • [4] Prevalence, Characteristics, Management, and Outcomes of Difficult-to-Treat Inflammatory Bowel Disease
    Parigi, Tommaso Lorenzo
    Massimino, Luca
    Carini, Alfredo
    Gabbiadini, Roberto
    Bertoli, Peter
    Allocca, Mariangela
    Bezzio, Cristina
    Dal Buono, Arianna
    D'Amico, Ferdinando
    Furfaro, Federica
    Loy, Laura
    Zilli, Alessandra
    Ungaro, Federica
    Jairath, Vipul
    Peyrin-Biroulet, Laurent
    Armuzzi, Alessandro
    Danese, Silvio
    JOURNAL OF CROHNS & COLITIS, 2024,
  • [5] Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey
    Parigi, Tommaso Lorenzo
    D'Amico, Ferdinando
    Abreu, Maria T.
    Rubin, David T.
    Dignass, Axel
    Dotan, Iris
    Jairath, Vipul
    Magro, Fernando
    Peyrin-Biroulet, Laurent
    Ghosh, Subrata
    Danese, Silvio
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05): : 390 - 391
  • [6] Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
    Parigi, Tommaso Lorenzo
    D'Amico, Ferdinando
    Abreu, Maria
    Dignass, Axel
    Dotan, Iris
    Magro, Fernando
    Griffiths, Anne M.
    Jairath, Vipul
    Iacucci, Marietta
    Mantzaris, Gerassimos J.
    O'Morain, Colm
    Reinisch, Walter
    Sachar, David B.
    Turner, Dan
    Yamamoto, Takayuki
    Rubin, David
    Peyrin-Biroulet, Laurent
    Ghosh, Subrata
    Danese, Silvio
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (09): : 853 - 859
  • [7] Randomized Clinical Trials in Inflammatory Bowel Disease
    Cottone, Mario
    REVIEWS ON RECENT CLINICAL TRIALS, 2012, 7 (04) : 255 - 255
  • [8] CLINICAL SUPERVISION OF THERAPISTS WITH DIFFICULT-TO-TREAT PATIENTS
    ADELSON, MJ
    BULLETIN OF THE MENNINGER CLINIC, 1995, 59 (01) : 32 - 52
  • [9] Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
    Raab, Marc S.
    Zamagni, Elena
    Manier, Salomon
    Rodriguez-Otero, Paula
    Schjesvold, Fredrik
    Broijl, Annemiek
    EJHAEM, 2023, 4 (04): : 1117 - 1131
  • [10] Clinical trials probe new therapies for some difficult-to-treat cancers
    Hampton, Tracy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (04): : 384 - 385
12345